Публикувани изследвания на PiLeJe в областта на микробиота

⦁ Drouault-Holowacz S, Foligné B, Dennin V, Goudercourt D, Terpend K, Burckel A, Pot B. Anti-inflammatory potential of the probiotic dietary supplement Lactibiane Tolerance: in vitro and in vivo considerations. Clin Nutr. 2006; 25 (6): 994-1003.
⦁ Nebot-Vivinus M, Harkat C, Bzioueche H, Cartier C, Plichon-Dainese R, Moussa L, Eutamene H, Pishvaie D, Holowacz S, Seyrig C, Piche T, Theodorou V. Multispecies probiotic protects gut barrier function in experimental models. World J Gastroenterol. 2014 Jun 14; 20 (22): 6832-43.
⦁ Holowacz S, Guigne C, G Oak, Mouysset S, Guilbot A, Seyrig C, Dubourdeau M. Multispecies Lactobacillus- and Bifidobacterium-containing probiotic mixture attenuates body weight gain and insulin resistance after a short-term challenge with a high-fat diet in C57 / BL6J mice. PharmaNutrition. 2015 Jul; 3 (3): 101-7.
⦁ Neau E, Delannoy J, Marion C, Cottart CH, Labellie C, Holowacz S, Butel MJ, N Kapel, Waligora-Dupriet AJ.Three Novel Candidate Probiotic Strains with Prophylactic Properties in a Murine Model of Cow’s Milk Allergy. Appl Environ Microbiol. 2016; 82 (6): 1722-1733. doi: 10.1128 / AEM.03440-15.
⦁ Holowacz S, Blondeau C, Guinobert I, Gililbot A, Hidalgo-Lucas S, Bisson JF. (2016) Antidiarrheal and Antinociceptive Effects of a Probiotic Mixture in Rats. J Prob Health 4: 155. doi: 10.4172 / 2329-8901.1000155
⦁ Van Hul M, Geurts L, Plovier H, Druart C, Everard A, Ståhlman M, Rhimi M, Chira K, Teissedre PL, Delzenne NM, Maguin E, Guilbot A, Brochot A, Gerard P, Bäckhed F, Cani PD. Reduced obesity, diabetes, and steatosis upon cinnamon and grape pomace are associated with changes in microbiota and markers of gut barrier. Am J Physiol Endocrinol Metab. 2017 Sep 5: ajpendo.00107.2017. doi: 10.1152 / ajpendo.00107.2017
⦁ Holowacz S, Blondeau C, Guinobert I, Guilbot A, Hidalgo S, Bisson JF. Lactobacillus salivarius LA307 and Lactobacillus rhamnosus LA305 attenuate skin inflammation in mice. Lactobacillus salivarius LA307 and Lactobacillus rhamnosus LA305 attenuate skin inflammation in mice. Beneficial Microbes 2018, Vol. 9, No. 2, pp. 299-309
⦁ Alard J, Peucelle V, Boutillier D, Breton J, Kuylle S, Pot B, Holowacz S, Grangette C. Probiotic strains with a high potential for inflammatory bowel disease management by in vitro and in vivo approaches. Beneficial Microbes 2018, Vol. 9, No. 2, pp. 317-331
⦁ Holowacz S, Guinobert I, Guilbot A, Hidalgo S, Bisson JF. A mixture of five bacterial strains attenuates skin inflammation in mice. Antiinflamm Antiallergy Agents Med Chem. 2018 Aug 13.
⦁ Drouault-Holowacz S, Bieuvelet S, Burckel A, Hammer P. Double-blind randomized controlled trial of a probiotic combination in 100 patients with irritable bowel syndrome. Gastroenterol Clin Biol. 2008; 32 (2): 147-52.